"Hey CIRI, What's My Prognosis?".
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 31348884.
- Also identified by DOI 10.1016/j.cell.2019.07.005.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although serial tumor assessments are increasingly performed through imaging and molecular approaches, such evaluations are often considered in isolation, as robust frameworks for integrating multiple biomarkers are currently lacking. Thus, in this issue of Cell, Kurtz et al. present a method (termed CIRI) that integrates pre-treatment and on-treatment risk factors for accurate outcome prediction.
Medical subject headings
- Biomarkers, Tumor